The WATCHMAN™ Left Atrial Appendage Closure Device is a permanent implant designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke.
WATCHMAN is for people who:
WATCHMAN is a one-time procedure that reduces the risk of stroke in people with atrial fibrillation. WATCHMAN is as effective at reducing the risk of stroke as warfarin. But unlike warfarin, the WATCHMAN Implant also reduces the long-term risk of bleeding. Newer blood thinners offer an option to warfarin, but they don't take away the long-term risk of bleeding.
WATCHMAN is implanted like a stent, by means of a narrow tube inserted through a small cut in your upper leg. Your doctor will then guide the WATCHMAN into your heart. The procedure is done under general anesthesia and takes about an hour. Patients commonly stay in the hospital overnight and leave the next day.
The WATCHMAN Implant has a proven record of safety—with over 20,000 procedures performed worldwide and over 10 years of clinical studies in more than 2,000 patients. It is the only device of its kind approved by the U.S. Food and Drug Administration.
Patients who should not receive the implant include, but are not limited to:
Be sure to talk with your doctor about the risks and benefits associated with the WATCHMAN Device.
Source: Boston Scientific Corporation
Referring physicians may call 469.814.3565 to schedule a patient for evaluation. For a physician referral, patients may call 1.855.822.9567.
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.